Product Showcase

The HHS Intramural Research Programs have invented numerous technologies that were licensed to companies for commercial development and now are on the market. Products showcased on this site are utilized every day to detect, treat or prevent disease or assist researchers as they continue to explore ways to develop newer and more effective health care products and procedures.

The Showcase includes products that are now or have been on the market. Some are FDA-approved and many do not necessitate FDA approval. While there may be multiple inventors on any product, all of whom may not be from HHS, the primary purpose of this Showcase is to highlight the contributions of HHS. 

We hope you will find this Showcase illuminating about the role the HHS Intramural Research Programs have played in the effort to advance significantly our capacity to protect and improve health.

Upstate Biotechnology, Incorporated

Antibodies used to target a protein phosphatase that plays a role in immunosupression

Calypte Biomedical Corporation, Inc.

Measures time since HIV-1 infection occurred.

Maxim Biomedical , Inc.

Confirmation of antibodies to HIV-1 in human serum and plasma

Arcturus Engineering, Inc.

Precisely dissects cancerous cells from biopsies for study

Biocare Medical, LLC

Detects early foci of gastric carcinoma and distinguishes pulminary adenocarcinomas from mesothelioma

Clontech Laboratories, Inc

Designed to clone full-length cDNA into a plasmid vector, pDNR-Lib

Baxter International, Inc.

Combined diphtheria, tetanus and acellular pertussis vaccine for use in infants and children

GlaxoSmithKline

Vaccine for human papilloma virus (HPV) to protect from cancers

Sigma-Aldrich

Useful for solubilizing animal cell membrane proteins

Invitrogen Corporation

It provides a highly sensitive and efficient method for the in-vitro modification of O-GlcNAc modified proteins

BD PharMingen

Biological materials used in research and treatment development for allergies, cancer, and parasites

BioNTech, Pfizer

Prevention of COVID-19.

Trevigen, Inc.

Ideal for cell invasion, tissue regrowth, and cancer development studies

Trevigen, Inc.

Designed for assessing angiogenesis activation

Trevigen, Inc.

Designed for assessing angiogenesis activation

Trevigen, Inc.

Angioreactor optimizes sensitivity and provides a more controlled experiment

Trevigen, Inc.

Designed for assessing angiogenesis inhibition

PanVera LLC

Inhibits the CYP2A6 activity

Sanofi

Prevention of dengue disease in individuals 9-16 years old with prior dengue infection.

Adaltis

Screens for HIV virus

Anmed/Biosafe, Inc.

Detects the presence of bacteria or viruses in different organisms

Barr Laboratories, Inc.

Treatment of HIV infection with dideoxyinosine (generic equivalent for Videx® EC)

Sigma-R.B.I.

Long-acting nitric oxide donor

Cayman Chemical Company

Research tool/reagent for nonhuman investigations

Macrocyclics, Inc.

Material for the treatment for contamination of radioactive material

Covance Research Products, Inc.

MRI technique to help diagnose problems in the brain

Siemens Aktiengesellschaft

Mapping white matter in brain using MRI

Oncoscreen GmbH

To identify Exon 14-Skipping Mutation in the DPD-gene for cancer patients.

DUALSYSTEMS Biotech, AG

Screen full-length integral membrane proteins in vivo

Ridgeback Biotherapeutics

Treatment of Zaire ebolavirus infection.